Cryoport, Inc. (CYRX): Free Cash Flow
-$25.02M
Year ended 2025-12-31
-$20.03M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$25.02M | n/m | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | -$33.58M | n/m | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | -$39.54M | n/m | 2026-03-05, From 2023-01-01 |
| 2022-12-31 | -$23.96M | n/m | 2025-03-07, From 2022-01-01 |
| 2021-12-31 | -$15.76M | n/m | 2024-03-13, From 2021-01-01 |
| 2020-12-31 | -$23.78M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$6.66M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$6.27M | n/m | 2020-03-10, From 2018-01-01 |
| 2017-12-31 | -$5.30M | n/m | 2019-03-13, From 2017-01-01 |
| 2016-12-31 | -$6.78M | n/a | 2018-03-08, From 2016-01-01 |
| No annual figure between 2015-03-31 and 2016-12-31. | |||
| 2015-03-31 | -$4.20M | n/m | 2016-06-28, From 2014-04-01 |
| 2014-03-31 | -$4.52M | n/m | 2015-05-19, From 2013-04-01 |
| 2013-03-31 | -$4.94M | n/m | 2014-06-25, From 2012-04-01 |
| 2012-03-31 | -$7.04M | n/m | 2013-06-25, From 2011-04-01 |
| 2011-03-31 | -$5.15M | n/a | 2012-06-27, From 2010-04-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | 2025-12-31 | -$25.02M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$167.00M | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$323.17M | n/m |
| Lifevantage Corp (LFVN) | 2026-06-30 | $6.67M | -36.5% |
| Stoke Therapeutics, Inc. (STOK) | 2025-12-31 | $44.91M | n/m |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 2025-12-31 | -$70.72M | n/m |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | -$116.63M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$40.02M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$27.91M | n/m |
Compare CYRX, PHAT, SNDX, LFVN side by side · Screen every company in Pharmaceutical Preparations ↗